Global Stents Market Outlook
The global stents market size was valued at USD 12.5 billion in 2023, driven by rising prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 5.6% during the forecast period of 2024-2032, with the values likely to reach USD 20.4 billion by 2032.
Stents: Introduction
Stents are small, tube-shaped devices inserted into blood vessels, arteries, or other hollow structures to keep them open and ensure proper blood flow or passage of fluids. Commonly made from metal or plastic, stents are crucial in treating conditions such as coronary artery disease, where they help prevent artery blockages and subsequent heart attacks. The procedure to place a stent, known as angioplasty, is minimally invasive and significantly improves patient outcomes by reducing the risk of severe cardiovascular events. Advances in stent technology, including drug-eluting stents, have further enhanced their effectiveness, reducing the likelihood of restenosis and the need for additional interventions.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/stents-market/requestsample
Key Trends in the Global Stents Market
The global stents market is witnessing rapid growth, driven by technological advancements and increasing prevalence of cardiovascular diseases. Key trends in this market are shaping the future of cardiovascular care, improving patient outcomes, and expanding treatment options.
One significant trend is the advancement in stent technology, particularly the development of drug-eluting stents (DES). These stents are coated with medication that is slowly released to prevent the re-narrowing of blood vessels (restenosis). DES has significantly improved patient outcomes by reducing the need for repeat procedures and enhancing long-term vessel patency.
Another important trend is the emergence of bioresorbable stents. Unlike traditional metal stents, bioresorbable stents are designed to dissolve naturally within the body after fulfilling their purpose of keeping the blood vessel open. This innovation reduces long-term complications associated with permanent implants and promotes natural vessel healing.
The increasing adoption of minimally invasive procedures is also driving the stents market. Percutaneous coronary interventions (PCI) and other catheter-based procedures offer faster recovery times, reduced hospital stays, and lower overall costs compared to traditional open-heart surgeries. The preference for these less invasive options is boosting the demand for advanced stent technologies.
A growing focus on personalised medicine is influencing the stents market. Advances in imaging technologies and diagnostic tools enable healthcare providers to tailor stent selection and placement to the individual needs of patients, optimising treatment efficacy and safety. Personalised stent solutions are particularly beneficial for patients with complex cardiovascular conditions.
The integration of digital health technologies and remote monitoring systems is another emerging trend. Smart stents equipped with sensors can provide real-time data on blood flow and vessel health, allowing for continuous monitoring and timely interventions. This technological integration enhances patient management and supports proactive healthcare.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/stents-market
Global Stents Market Segmentation
Market Breakup by Product Type
- Coronary Stents
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Peripheral Stents
- Iliac Stent
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
- Neurovascular Stents
- Stent-Related Implants
- Synthetic Grafts
- Vena Cava Filters
Market Breakup by Type
• Self-Expandable Stents
• Balloon-Expandable Stents
Market Breakup by Material
• Metallic Stents
• Polymer Stents
• Bioresorbable Stents
• Others
Market Breakup by End User
• Hospitals
• Ambulatory Surgical Centres
• Others
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Global Stents Market Overview
The global stents market is experiencing substantial growth, driven by technological advancements, increasing prevalence of cardiovascular diseases, and a rising demand for minimally invasive procedures. Each region contributes uniquely to the market dynamics, shaping the overall landscape.
In North America, the stents market is well-developed, supported by advanced healthcare infrastructure, high healthcare expenditure, and significant investment in research and development. The United States leads this region, driven by a high prevalence of cardiovascular diseases, robust healthcare policies, and a strong emphasis on innovative medical technologies. The availability of advanced stents, including drug-eluting stents (DES) and bioresorbable stents, enhances patient outcomes and reduces complications. Canada also contributes significantly to the market, supported by increasing awareness of cardiovascular health and government initiatives promoting advanced medical treatments.
Europe represents a substantial market for stents, characterised by high standards of medical care, extensive healthcare coverage, and a strong emphasis on research and innovation. Key contributors include Germany, France, the United Kingdom, and Italy. Germany benefits from extensive healthcare coverage and significant investment in medical research, facilitating access to advanced stent technologies. France’s focus on comprehensive healthcare and patient education supports the demand for effective cardiovascular treatments. The UK’s proactive healthcare policies and emphasis on preventive care drive market growth, while Italy benefits from increasing healthcare infrastructure investments and growing awareness of cardiovascular health.
The Asia Pacific region presents lucrative growth opportunities for the stents market, driven by a large and growing population, increasing healthcare expenditure, and rising prevalence of cardiovascular diseases. Countries such as China, Japan, India, and South Korea are major contributors. China’s expanding healthcare infrastructure and growing middle-class population drive the demand for advanced cardiovascular treatments, including stents. Japan, with its advanced healthcare system and significant focus on cardiovascular health, contributes to market growth through the adoption of innovative stent technologies. India and South Korea are witnessing increasing awareness and demand for effective cardiovascular treatments, supported by government initiatives and rising healthcare investments.
Latin America is emerging as a promising market for stents, supported by improving healthcare infrastructure, increasing awareness of cardiovascular health, and rising healthcare expenditure. Countries like Brazil, Mexico, and Argentina are witnessing growing demand for advanced stent technologies due to the high prevalence of cardiovascular diseases and other chronic conditions. Government initiatives to improve healthcare access and affordability drive market growth. Local manufacturers are also expanding their product portfolios to include innovative stent solutions, enhancing the availability of effective cardiovascular treatments in the region.
The Middle East and Africa (MEA) region is experiencing steady growth in the stents market, driven by increasing healthcare investments, rising prevalence of cardiovascular diseases, and growing awareness of the importance of early diagnosis and treatment. Countries such as Saudi Arabia, the UAE, and South Africa are key contributors. Saudi Arabia and the UAE benefit from significant healthcare infrastructure investments and adoption of advanced medical technologies. South Africa, with its focus on improving healthcare accessibility and affordability, supports the growing demand for cardiovascular treatments. Public health campaigns and educational initiatives about cardiovascular health also contribute to the increasing demand for effective stent solutions in the MEA region.
Global Stents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
• Boston Scientific Corporation
Boston Scientific Corporation, established in 1979, is a leading global medical device company headquartered in Marlborough, Massachusetts, USA. The company specialises in developing and manufacturing innovative medical solutions for a wide range of conditions, including cardiovascular, digestive, respiratory, and urological diseases. Renowned for its cutting-edge technologies, Boston Scientific offers products such as stents, catheters, and implantable defibrillators that improve patient outcomes and enhance the quality of life. The company’s commitment to research and development, along with its focus on patient-centred care, has made it a trusted name in the healthcare industry, serving millions of patients worldwide with advanced medical devices and therapies.
• BD
BD (Becton, Dickinson and Company), established in 1897, is a leading global medical technology company headquartered in Franklin Lakes, New Jersey, USA. The company specialises in the development, manufacture, and sale of medical devices, laboratory equipment, and diagnostic products. BD is renowned for its innovations in areas such as infection prevention, medication management, diabetes care, and biosciences. Committed to advancing healthcare, BD collaborates with institutions and healthcare professionals worldwide to improve patient outcomes and enhance safety. The company’s dedication to quality and continuous improvement has made it a trusted name in the healthcare industry globally, impacting lives through its comprehensive healthcare solutions.
• Medtronic
Medtronic, established in 1949, is a global leader in medical technology headquartered in Dublin, Ireland. The company specialises in developing innovative solutions to address complex health conditions across various therapeutic areas, including cardiovascular, diabetes, neurological, and spinal disorders. Medtronic’s mission is to alleviate pain, restore health, and extend life for millions of patients worldwide. With a strong commitment to research and development, Medtronic continuously advances medical technology and collaborates with healthcare professionals to improve patient outcomes. The company’s comprehensive portfolio of products and services makes it a trusted name in the healthcare industry, known for its dedication to enhancing quality of life through medical innovation.
• Abbott
Abbott, established in 1888, is a global healthcare company headquartered in Abbott Park, Illinois, USA. The company specialises in developing a wide range of healthcare products, including diagnostics, medical devices, nutritionals, and branded generic medicines. Abbott is renowned for its innovative solutions in areas such as diabetes care, cardiovascular health, and infectious diseases. With a strong commitment to improving lives through cutting-edge technology and research, Abbott collaborates with healthcare professionals worldwide to enhance patient care and outcomes. The company’s dedication to quality and continuous innovation has made it a trusted name in the global healthcare industry.
• Cook Medical
Cook Medical, established in 1963, is a globally renowned medical device company headquartered in Bloomington, Indiana, USA. The company specialises in developing and manufacturing minimally invasive medical devices across a wide range of medical fields, including radiology, cardiology, endoscopy, and urology. Known for its innovative products and commitment to improving patient outcomes, Cook Medical collaborates closely with healthcare professionals to develop cutting-edge solutions that address unmet medical needs. The company’s extensive product portfolio and focus on research and development have made it a trusted name in the healthcare industry, dedicated to enhancing the quality of patient care worldwide.
Other key players in the market are Merit Medical Systems, Novatech SA, Terumo Corporation, MicroPort Scientific Corporation, Fuji Systems Corp., MICRO-TECH EUROPE, Vascular Concepts, Olympus Corporation, W. L. Gore & Associates Inc., and B. Braun Melsungen AG.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Jhon Roy, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
